Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Prevention of Vascular Graft Infection With Hypochlorous Acid

NCT: NCT07678632 · NOT_YET_RECRUITING

NCT IDNCT07678632
StatusNOT_YET_RECRUITING
Start Date2026-08-03
Completion2028-08-03
SponsorHamilton Health Sciences Corporation (OTHER)
First posted
Last updated

Brief Summary

This is a study of the use of an antibacterial solution, Hypochlorous acid, to prevent infection in vascular surgery bypass grafts. The solution will be used at the end of operations to insert a prosthetic vascular surgery bypass graft, to wash the wound and the vascular bypass graft before the wound is closed. The patients in this study will be undergoing surgery for problems with narrowed and or blocked arteries. The presence or absence of a graft infection will be followed for 12 months following the surgery. Prosthetic vascular graft infections have significant implications for patients with high rates of death and amputation, hence preventing them will have significant benefits for patients and the health care system.

Frequently Asked Questions

What is Prevention of Vascular Graft Infection With Hypochlorous Acid?

Prevention of Vascular Graft Infection With Hypochlorous Acid is a clinical trial registered under NCT07678632. Current status: NOT_YET_RECRUITING.

What is the status of NCT07678632?

The current status of NCT07678632 (Prevention of Vascular Graft Infection With Hypochlorous Acid) is: NOT_YET_RECRUITING.

When did Prevention of Vascular Graft Infection With Hypochlorous Acid start?

Prevention of Vascular Graft Infection With Hypochlorous Acid started on 2026-08-03.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.